Medical News Today - Research Provides New Clues For Schizophrenia Drug Development
Around one percent of the world's population suffers from schizophrenia. However, around 30 percent of patients do not respond to current drugs for treating schizophrenia. In a study published online in Nature Neuroscience, researchers of the Mount Sinai School of Medicine may now have discovered the reasons for this. The discovery opens the door for a new class of drugs that can help in treating this devastating mental illness. Leading researcher Javier Gonzalez-Maeso, PhD, Assistant Professor of Psychiatry and Neurology at Mount Sinai School of Medicine, said: "These results are groundbreaking because they show that drug resistance may be caused by the very medications prescribed to treat schizophrenia, when administered chronically."
- Dr. Javier Gonzalez-Maeso, Assistant Professor, Psychiatry, Neurology, Mount Sinai School of Medicine